About Us
Our Company
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Search
Search
Toggle Menu
Search
Search
Toggle Menu
About Us
Toggle Menu
Our Company
Executive Leadership
Locations
Toggle Menu
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
Toggle Menu
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Toggle Menu
Offerings
Toggle Menu
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Toggle Menu
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Toggle Menu
Press Releases
Events
Thought Leadership
Resources
Toggle Menu
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Toggle Menu
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Our Company
About Us
Our History
Mission & Values
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Policies
Environment, Health & Safety
Group Privacy Policies
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fact Sheets
Global Manufacturing Capabilities (PDF)
CHEF1
TM
Expression Technology (PDF)
Analytical, Formulation and Stability (PDF)
Process Development (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
News
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
In the Spotlight
Win the Cell & Gene Therapy Race with AGC Biologics
Join Our Team
Career Opportunities
Life at a CDMO
Diversity, Equity & Inclusion
Amplify your career. Make an impact.
Press Releases
Filter by Tag
All
Company News
Events
News
Partnership
1 min read
AGC Biologics Appoints Whitney Sandberg as the new Vice President of Quality for its Colorado Facilities
December 27, 2021 at 10:21 AM
Company News
Read More
1 min read
I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project
December 13, 2021 at 5:00 PM
News
Read More
2 min read
AGC Biologics Receives Transatlantic Award for Investments in Milan Biopharmaceutical Industry
December 7, 2021 at 10:39 AM
News
Read More
2 min read
4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab
December 1, 2021 at 6:03 AM
News
Company News
Read More
1 min read
AGC Biologics Appoints Jean-Baptiste Agnus as Chief Business Officer
November 1, 2021 at 6:00 AM
News
Read More
2 min read
AGC Biologics Expands pDNA and mRNA Manufacturing Capacity
September 13, 2021 at 5:00 PM
News
Read More
2 min read
AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site
August 20, 2021 at 10:30 AM
News
Read More
1 min read
AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site
August 9, 2021 at 10:00 PM
News
Read More
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
August 5, 2021 at 9:00 AM
News
Read More
1 min read
AGC Biologics Appoints Kevin Ingham as the new General Manager/Site Head of their Seattle, Washington Site
August 2, 2021 at 11:00 AM
News
Read More
Prev
1
2
3
4
5
Next
